STROMECTOL

LOE Approaching

ivermectin

Merck & Co.
NDAORALTABLETPriority Review
Approved
Nov 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
7

Mechanism of Action

Pharmacologic Class:

Antiparasitic

Clinical Trials (5)

NCT03717558Phase 1Withdrawn

Bioavailability Pilot Study of Versus W0035 Versus Stromectol

Started Apr 2018
0
Healthy Volunteers
NCT03301649Phase 3Completed

Clinical Endpoint Study of Ivermectin 0.5% Lotion

Started Oct 2017
905 enrolled
Head Lice
NCT03286101Phase 2Completed

Efficacy and Safety of Topical 0.5% Ivermectin Lotion for the Treatment of Head Lice Infestation in Filipinos

Started Sep 2017
120 enrolled
Pediculosis Capitis
NCT00921219Phase 1Completed

Ivermectin Solution Bioequivalence Study - With Food (Repeat)

Started Sep 2005
34 enrolled
Healthy
NCT00921154Phase 1Completed

Ivermectin Solution Bioequivalence Study - Fasted

Started Mar 2005
24 enrolled
Healthy
Company
M&
Merck & Co.
RAHWAY, NJ
674 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers
Data Sources
  • Drug label: DailyMed / FDA
  • Clinical trials: ClinicalTrials.gov
  • Patent data: FDA Orange Book
  • Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.